Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
EXL named a Leader in 2024 Gartner® Magic Quadrant™ for Finance and Accounting Business Process Outsourcing
-
African Rainbow Minerals Limited Acquires Shares of Surge Copper Corp.
-
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting
-
IBN Announces Latest Episode of The Stock2Me Podcast featuring Brian J. Esposito, CEO of Diamond Lake Minerals Inc.
-
German American Bancorp, Inc. announces the sale of the assets of German American Insurance, Inc. to Hilb Group
-
GDS to Hold Annual General Meeting on June 27, 2024
-
Paradies Lagardère Introduces ARHT Holograms in New Retail Experience at Toronto Pearson International Airport
-
KP Tissue Reminds Shareholders to Vote in Advance of Deadline for 2024 Annual Meeting of Shareholders
-
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
-
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce Bottles
-
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives an Extension on Compliance with Nasdaq Filing Requirement
-
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
-
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device
-
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
-
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
-
Beyond, Inc. to Participate in Upcoming Investor Conferences
-
LCS Announces 2024 Chef of the Year Finalists
-
Form 8.3 - Irish Residential Properties REIT plc
-
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
-
Report on transactions of executives and related parties in ROCKWOOL A/S shares
-
Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
-
Molecular Templates, Inc. Provides Interim Update
-
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)
-
Coherent Appoints Jim Anderson as Chief Executive Officer
-
Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
-
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
-
InnovAge PACE Recertified as a Great Place to Work
-
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
-
Ready Capital to Present at Nareit’s REITweek 2024
-
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
-
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
-
Texas Must Close Primary Elections
-
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeti
-
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
-
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
-
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
-
BriaCell Presents Clinical Efficacy Data at ASCO 2024
-
Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
-
Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024
-
PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
Enphase Energy Launches IQ Battery 5P in Canada
-
KULR Announces Expiration of SEPA Facility and Compliance with NYSE Guidelines on Audit Opinion Disclosure
-
Apogee Minerals Announces Appointment of New Director
-
ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases
-
ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
-
Abacus Life and AIMCOR Announce New National Distribution Agreement
